Deals set to boost Trilogy sales overseas
Skincare brand Trilogy has signed two new major distribution deals in Australia and Britain that will increase its exports by hundreds of thousands of units a year.
Trilogy products for face and body care, based on certified organic rosehip oil extract, will now be sold at all 27 outlets of upmarket department store John Lewis across England, Scotland and Wales, and in 450 Australian pharmacies owned by Sigma Group.
The beauty company was started by Wellington sisters Sarah Gibbs and Catherine de Groot in 2002 and was sold to NZX-listed Ecoya for $20 million in 2010, although Gibbs retains an active role in running the company.
Its moisturisers, lip balms and anti-ageing firming serums are made at an Auckland factory from ingredients certified natural by Belgian authority Natrue. In the six months to September, Trilogy made a $12.1m profit, up from $10.4m a year earlier.
The brand is already stocked at 2000 outlets in Australia, including Priceline, but the new deal was expected to increase sales across the Tasman by at least another quarter. ASX-listed Sigma's pharmacy brands include Amcal and Guardian.
Both agreements took about a year of negotiations, Ecoya chief executive Stephen Sinclair said. Its best-selling products, Certified Organic Rosehip Oil and Rosehip Oil Antioxidant+, had been stocked at the John Lewis original flagship store in Oxford St, London, for about a year and the wider range would now be available at each of its stores and on its website. Trilogy was already stocked in some Boots chemists in Britain.
"It's big for us," Sinclair said.
"John Lewis stores have a nice profile, so that's exciting.
"I was up there about this time last year talking to them. It gives us the opportunity to build Trilogy.
"In Australia, from a footprint perspective, we're really happy with where our distribution sits . . . this gives us more opportunity to get some noise going about the brand."
Trilogy products are now sold at stores in 16 countries.
The Dominion Post